FDA to Review Efgartigimod for Generalized Myasthenia Gravis By Brian Park, PharmD Publish Date March 2, 2021
Cosela Now Available to Reduce Chemotherapy-Induced Bone Marrow Suppression in ES-SCLC By Brian Park, PharmD Publish Date March 2, 2021
Varenicline Nasal Spray Under Review for Dry Eye Disease By Brian Park, PharmD Publish Date March 2, 2021
Keytruda Indication for Metastatic Small Cell Lung Cancer Withdrawn By Brian Park, PharmD Publish Date March 2, 2021
Vazalore, a Liquid-Filled Capsule Formulation of Aspirin, Gets FDA Approval By Brian Park, PharmD Publish Date March 2, 2021
Nulibry Approved for Molybdenum Cofactor Deficiency Type A By Brian Park, PharmD Publish Date March 1, 2021
FDA to Review Once-Nightly Sodium Oxybate Formulation for Narcolepsy By Brian Park, PharmD Publish Date March 1, 2021
Gefapixant Under Review for Refractory Chronic Cough By Brian Park, PharmD Publish Date March 1, 2021
Pepaxto Approved for Triple-Class Refractory Multiple Myeloma By Brian Park, PharmD Publish Date March 1, 2021
Benralizumab May Reduce or Eliminate Oral Corticosteroid Use in Severe Asthma By Brandon May Publish Date March 1, 2021
Berotralstat May Reduce On-Demand Medication Use in Hereditary Angioedema By Virginia A. Schad, PharmD, RPh Publish Date March 1, 2021
Janssen’s Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization By Diana Ernst, RPh Publish Date March 1, 2021
